Neramexane for the treatment of nystagmus

Details for Australian Patent Application No. 2008258787 (hide)

Owner Merz Pharma GmbH & Co. KGaA

Inventors Hanschmann, Angelika; Stoffler, Albrecht; Althaus, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008258787

PCT Pub. Number WO2008/148564

Priority 08006925.5 07.04.08 EP; 60/933,808 08.06.07 US; 07252336.8 08.06.07 EP

Filing date 6 June 2008

Wipo publication date 11 December 2008

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/10 (2006.01) Drugs for disorders of the senses

Event Publications

19 November 2009 PCT application entered the National Phase

  PCT publication WO2008/148564 Priority application(s): WO2008/148564

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008258793-Pyrazole carboxylic acid amides useful as microbiocides

2008258782-Methods and means for exact replacement of target DNA in eukaryotic organisms